HCPLive Network

New Agent Significantly Improves Progression-Free Survival in Patients With Advanced ER+ Breast Cancer

Combining the investigational PD 0332991 with letrozole as first-line therapy extended progression-free survival in women with advanced estrogen-receptor positive breast cancer.

Click here to view this article.


Further Reading
Scientists in the United Kingdom recently uncovered a new ‘family’ of drugs called padRAF inhibitors that are effective in treating melanoma patients who are resistant to BRAF inhibitors.
Researchers from the University of Missouri recently published study results indicating testosterone may play an integral role within colon cancer tumor formation.
Therapy prevents suicide and more attempts in patients who have previously attempted suicide, according to a study published in The Lancet Psychiatry.
More Reading